Gene · 26826
Papers2,447
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,447
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Influenza a virus regulates interferon signaling and its associated genes; MxA and STAT3 by cellular miR-141 to ensure viral replication. | Virol J | 2023 | 37596622 | PubTator, text mining | PubMed |
| Experimental Study of Warburg Effect in Keloid Nodules: Implication for Downregulation of miR-133b. | Plast Reconstr Surg Glob Open | 2023 | 37593704 | PubTator, text mining | PubMed |
| Differential miRNA expression of hypoxic MCF7 and PANC-1 cells. | Front Endocrinol (Lausanne) | 2023 | 37583428 | PubTator, text mining | PubMed |
| Dysregulation of PLOD2 Promotes Tumor Metastasis and Invasion in Hepatocellular Carcinoma. | J Clin Transl Hepatol | 2023 | 37577214 | PubTator, text mining | PubMed |
| Serum tRF-27-FDXXE6XRK45 as a Promising Biomarker for the Clinical Diagnosis in Gastric Cancer. | Int J Med Sci | 2023 | 37575270 | PubTator, text mining | PubMed |
| Plasma Exosomal microRNA Profile Reveals miRNA 148a-3p Downregulation in the Mucosal-Dominant Variant of Pemphigus Vulgaris. | Int J Mol Sci | 2023 | 37511259 | PubTator, text mining | PubMed |
| Roles of miR-4442 in Colorectal Cancer: Predicting Early Recurrence and Regulating Epithelial-Mesenchymal Transition. | Genes (Basel) | 2023 | 37510319 | PubTator, text mining | PubMed |
| From Euglycemia to Recent Onset of Type 2 Diabetes Mellitus: A Proof-of-Concept Study on Circulating microRNA Profiling Reveals Distinct, and Early microRNA Signatures. | Diagnostics (Basel) | 2023 | 37510186 | PubTator, text mining | PubMed |
| Light-responsive microRNA molecules in human retinal organoids are differentially regulated by distinct wavelengths of light. | iScience | 2023 | 37485345 | PubTator, text mining | PubMed |
| Data Normalization of Urine miRNA Profiling from Head and Neck Cancer Patients Treated with Cisplatin. | Int J Mol Sci | 2023 | 37446060 | PubTator, text mining | PubMed |
| Baseline Expression of Exosomal miR-92a-3p and miR-221-3p Could Predict the Response to First-Line Chemotherapy and Survival in Metastatic Colorectal Cancer. | Int J Mol Sci | 2023 | 37445798 | PubTator, text mining | PubMed |
| miR-92a and integrin expression in fibrovascular membranes in proliferative diabetic retinopathy. | Front Ophthalmol (Lausanne) | 2023 | 37426784 | PubTator, text mining | PubMed |
| Defining the landscape of circular RNAs in neuroblastoma unveils a global suppressive function of MYCN. | Nat Commun | 2023 | 37402719 | PubTator, text mining | PubMed |
| Is there a potential of circulating miRNAs as biomarkers in rheumatic diseases? | Genes Dis | 2023 | 37397550 | PubTator, text mining | PubMed |
| Gold Nanoparticles Inhibit PMA-Induced MMP-9 Expression via microRNA-204-5p Upregulation and Deactivation of NF-κBp65 in Breast Cancer Cells. | Biology (Basel) | 2023 | 37372062 | PubTator, text mining | PubMed |
| An unnatural enzyme with endonuclease activity towards small non-coding RNAs. | Nat Commun | 2023 | 37355703 | PubTator, text mining | PubMed |
| Regulation of microRNA expression by the adaptor protein GRB2. | Sci Rep | 2023 | 37328606 | PubTator, text mining | PubMed |
| Panel of miR-150 and linc00673, regulators of CCR6/CCL20 may serve as non-invasive diagnostic marker of non-small cell lung cancer. | Sci Rep | 2023 | 37316552 | PubTator, text mining | PubMed |
| MiR-494 induces metabolic changes through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma. | J Exp Clin Cancer Res | 2023 | 37301960 | PubTator, text mining | PubMed |
| The potential role of micro-RNA 125b-5p level in predicting outcome from thrombolytic therapy in patients with acute ischemic stroke. | J Thromb Thrombolysis | 2023 | 37289370 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/26826/papers?page=4